Inventor · disambiguated record
Qi Chao
Also filed as: CHAO QI
25 granted patents·10 pending applications·318 citations·filing 2000–2022
96Inventor score
Files withAMBIT BIOSCIENCES CORP12SIGNAL PHARM LLC4BIOMARIN PHARM INC3CEPHALON INC3SIGNAL PHARM INC3
Top patents by PatentIndex Score
35 records- 0193US8129374B2Method of using imidazolothiazole compounds for the treatment of diseaseBHAGWAT SHRIPAD·Filed 2010·Granted Mar 6, 2012·34 cites·42 claims
- 0293US6897231B2Indazole derivatives as JNK inhibitors and compositions and methods related theretoSIGNAL PHARM INC·Filed 2001·Granted May 24, 2005·62 cites·26 claims
- 0390US8618289B2RAF kinase modulator compounds and methods of use thereofABRAHAM SUNNY·Filed 2009·Granted Dec 31, 2013·22 cites·26 claims
- 0490US7820657B2Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2007·Granted Oct 26, 2010·13 cites·37 claims
- 0589US9320739B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Granted Apr 26, 2016·6 cites·11 claims
- 0688US8969587B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2013·Granted Mar 3, 2015·8 cites·14 claims
- 0788US7446122B2Substituted indole derivativesCEPHALON INC·Filed 2004·Granted Nov 4, 2008·29 cites·37 claims
- 0887US6436923B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Aug 20, 2002·26 cites·50 claims
- 0986US8349851B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 8, 2013·9 cites·19 claims
- 1086US7220771B2Methods of using indazole derivatives as JNK inhibitorsSIGNAL PHARM LLC·Filed 2003·Granted May 22, 2007·22 cites·4 claims
- 1184US7314886B2Tetrahydropyrano-indole derivativesCEPHALON INC·Filed 2004·Granted Jan 1, 2008·25 cites·29 claims
- 1283US7211594B2Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewithSIGNAL PHARM LLC·Filed 2003·Granted May 1, 2007·23 cites·6 claims
- 1383US7208513B2Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewithSIGNAL PHARM LLC·Filed 2004·Granted Apr 24, 2007·16 cites·12 claims
- 1482US6686351B2Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2002·Granted Feb 3, 2004·15 cites·18 claims
- 1578US10053430B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2017·Granted Aug 21, 2018·1 cites·2 claims
- 1675US9730937B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Aug 15, 2017·1 cites·19 claims
- 1775US8927711B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Jan 6, 2015·2 cites·19 claims
- 1875US8921546B2Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2013·Granted Dec 30, 2014·1 cites·1 claims
- 1973US9682941B2Substituted biphenyl analogues as dual inhibitors of aromatase and sulfataseESTRYX PHARMA LTD·Filed 2013·Granted Jun 20, 2017·2 cites·16 claims
- 2073US2023079913A1Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 2173US2023089374A1Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 2270US8557810B2Imidazolothiazole compounds for the treatment of diseaseBHAGWAT SHRIPAD·Filed 2012·Granted Oct 15, 2013·1 cites·22 claims
- 2365US11384055B2Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2018·Granted Jul 12, 2022·0 cites·14 claims
- 2464US2015126505A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2014·Application pending·0 cites
- 2561US2017348320A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2017·Application pending·0 cites
- 2659US9308207B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Apr 12, 2016·0 cites·19 claims
- 2753US7279489B2Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM LLC·Filed 2003·Granted Oct 9, 2007·0 cites·7 claims
- 2853US2009099178A1Indazole compounds and methods of use thereofBHAGWAT SHRIPAD S·Filed 2008·Application pending·0 cites
- 2951US2011269740A1Jak kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2009·Application pending·0 cites
- 3048US2006004043A1Indazole compounds and methods of use thereofBHAGWAT SHRIPAD S·Filed 2004·Application pending·0 cites
- 3148US2005009876A1Indazole compounds, compositions thereof and methods of treatment therewithFiled 2003·Application pending·0 cites
- 3246US2006167259A1Direct racemization of indole derivativesCEPHALON INC·Filed 2006·Application pending·0 cites
- 3343US9676752B2Imidazolidine-2,4-dione derivativesIPSEN PHARMA SAS·Filed 2013·Granted Jun 13, 2017·0 cites·14 claims
- 3440US2013303533A1Azolopyridine and azolopyrimidine compounds and methods of use thereofCHAO QI·Filed 2011·Application pending·0 cites
- 3538US9975880B2Imidazolidine-2,4-dione dervativesIPSEN PHARMA SAS·Filed 2013·Granted May 22, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Qi Chao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →